Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 618 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Sagent introduces Acetazolamide injection

The product offered in a latex-free vial is generic equivalent to the carbonic anhydrase inhibitor Diamox. Acetazolamide for Injection features Sagent’s PreventIV Measures packaging and labeling, which intends

Galena reports increased Q3 net loss

Operating loss for third quarter of 2012 was $5.53m compared to operating loss $3.43m for the third quarter of 2011. The company reported a net loss of $31.22m,